Apyx Medical Corporation Common Stock (APYX) is a publicly traded Healthcare sector company. As of May 21, 2026, APYX trades at $3.79 with a market cap of $162.05M and a P/E ratio of -14.02. APYX moved -4.57% today. Year to date, APYX is +7.06%; over the trailing twelve months it is +154.36%. Its 52-week range spans $0.76 to $4.50. Analyst consensus is strong buy with an average price target of $6.00. Rallies surfaces APYX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Apyx Medical Corporation Common Stock (APYX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. APYX moved -4.57% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $3.79 |
| Market Cap | $162.05M |
| P/E Ratio | -14.02 |
| EPS | $-0.27 |
| Dividend Yield | 0.00% |
| 52-Week High | $4.50 |
| 52-Week Low | $0.76 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $52.84M |
| Net Income | $-11.11M |
| Gross Margin | 62.53% |
3 analysts cover APYX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $6.00.